Dalstep (Dalfampridine) is a potassium channel blocker. Dalstep (Dalfampridine) is intended to improve the ability to move in adult patients with multiple sclerosis, in whom this ability was impaired. Also the drug has shown its effectiveness in studies of spinal cord injuries (improvement of sensory, motor and pulmonary function, reduction of spasticity and pain), Parkinson`s disease, tetrodotoxin poisoning.
Always follow your doctor`s instructions when using Dalstep (Dalfampridine) to get the safest and most effective results from treatment. Typically, Dalstep (Dalfampridine) is taken 1 tablet 2 times a day. Dalstep (Dalfampridine) can be taken with or without food.
Tablets should be taken whole. Tablets cannot be divided, chewed or crushed.
If you missed a dose, take it as soon as you remember. Skip the missed dose if it is almost time for your next planned dose. Do not take an extra tablet to make up for the missed dose.
The use of Dalstep (Dalfampridine) may cause side effects in some patients including:
Contact your doctor immediately if you experience any serious or worrying symptoms!
Pregnancy and lactation: Dalstep (Dalfampridine) can be dangerous to use during pregnancy. Studies in animals have shown adverse effects on the fetus, but studies in humans are limited.
It is unknown whether Dalstep (Dalfampridine) gets into breast milk and whether it can harm a nursing baby. Limited human studies suggest that the drug can be a significant risk to the baby. You should stop breast-feeding while using this medicine.
Children: Dalstep (Dalfampridine) is not allowed for use on people less than 18 years.
Influence on the ability to drive vehicles, work with mechanisms: It is not known whether Dalstep (Dalfampridine) affects concentration and ability to drive. Do not drive if you have any symptoms that affect your ability to concentrate and respond.